Skip to content

Tech
Consumer
Financial
Politics
- Trump
- US Budget
Health
Basic Materials
- Agriculture
- Metals & Mining
  - Cobalt
  - Zinc
  - Gold
  - Silver
  - Lithium
  - Uranium
  - Copper
Energy
- Oil & Gas
- Alternative Energy
  - Biofuels
  - Hydro
  - Solar
Industrials

Search

SEARCH FOR AN ARTICLE

Search

Tech
Consumer
Financial
Politics
- Trump
- US Budget
Health
Basic Materials
- Agriculture
- Metals & Mining
  - Cobalt
  - Zinc
  - Gold
  - Silver
  - Lithium
  - Uranium
  - Copper
Energy
- Oil & Gas
- Alternative Energy
  - Biofuels
  - Hydro
  - Solar
Industrials

HomeNASDAQ:IDRA

NASDAQ:IDRA

Idera Pharmaceuticals Climbs 16.9%, Phase 3 Study Proceeds

Idera Pharmaceuticals Climbs 16.9%, Phase 3 Study Proceeds

September 11, 2017

LATEST NEWS

All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

Advertisers
Privacy Policy
Terms of Use
DMCA Policy
Disclaimer
Contact Us

SUBSCRIBE

To get email updates from StreetSignals.

I want e-mail alerts, updates, and offers and agree to the StreetSignals privacy policy.

Market Jar Media Inc. © 2024